CD274 and cancer: From April 2015 to April 2019, 100 consecutive advanced cancer patients, receiving anti-PD-1/PD-L1 checkpoint inhibitors at the oncology departments of St Salvatore Hospital in L’Aquila and SS Annunziata Hospital in Chieti, were eligible for the imaging analysis.